# Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin

> **NCT01818141** · PHASE4 · COMPLETED · sponsor: **Hartford Hospital** · enrollment: 34 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** Fidaxomicin

## Key facts

- **NCT ID:** NCT01818141
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-17
- **Primary completion:** 2014-12-15
- **Final completion:** 2014-12-15
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01818141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01818141, "Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01818141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*